- RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil
- RAMM is uniquely positioned as one of the only operators to have a Good Manufacturing Practices (GMP) certified cannabis formulation facility currently in operation in South America.
- The Company currently has multiple approved and registered products that have been authorized for sale in Uruguay and compassionate use in several Latin American countries, as well as a pipeline of new products in various stages of approval and development produced in the Company’s state of the art Good Manufacturing Practice (GMP) certified cannabis formulation facility.
- In this news release, forward looking statements relate, among other things, the Company’s strategies and objectives, and future expansion plans.
Read full article: globenewswire.com